160 related articles for article (PubMed ID: 8962185)
1. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
Lin Y; Rutgeerts O; Waer M
Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
[No Abstract] [Full Text] [Related]
2. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
3. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
Wang M; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
[No Abstract] [Full Text] [Related]
4. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
Lin Y; Waer M
Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
[No Abstract] [Full Text] [Related]
5. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
Lin Y; Goebels J; Vandeputte M; Waer M
Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
[No Abstract] [Full Text] [Related]
6. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
Stepkowski SM; Tu Y; Chou TC; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
[No Abstract] [Full Text] [Related]
7. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Smith S; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
[No Abstract] [Full Text] [Related]
8. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
[No Abstract] [Full Text] [Related]
9. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Stepkowski SM; Kahan BD
Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
[No Abstract] [Full Text] [Related]
10. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
Robertson A; Plenter R; Francis DM; Clunie GJ
Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
[No Abstract] [Full Text] [Related]
11. Cardiac allograft tolerance induction with limited immunosuppression.
Cohen DS; Fisher RA; Tarry WC; Tawes JW
J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
[TBL] [Abstract][Full Text] [Related]
12. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Morris RE
Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
[No Abstract] [Full Text] [Related]
13. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
[No Abstract] [Full Text] [Related]
14. Rapamycin effects on immunologic reconstitution.
Vogelsang GB; Hess AD
Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
[No Abstract] [Full Text] [Related]
15. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
Marquet RL; de Bruin RW; Heineman E; Jeekel J
Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
[No Abstract] [Full Text] [Related]
16. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J
Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698
[No Abstract] [Full Text] [Related]
17. Inhibition of ATG-induced experimental transplantation tolerance with LS2616.
Olausson M; Arvidsson N; Lukes D; Mjörnstedt L; Qi Z; Ekberg H; Gannedahl G; Tufveson G
Transplant Proc; 1995 Dec; 27(6):3541-3. PubMed ID: 8540092
[No Abstract] [Full Text] [Related]
18. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
[No Abstract] [Full Text] [Related]
19. Xanthines: ideal immunosuppressants for combination with cyclosporine?
Lin Y; Segers C; Mikhalsky D; Schönharting M; Waer M
Transplant Proc; 1996 Dec; 28(6):3102. PubMed ID: 8962202
[No Abstract] [Full Text] [Related]
20. Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy.
Nawrocki G; Grieb P; Górski A; Danielewicz R; Rowiński W
Transplant Proc; 1996 Dec; 28(6):3538-9. PubMed ID: 8962374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
